How Do You Treat PV Patients That Fail Hydroxyurea (HU)?
Автор: Oncology.TV
Загружено: 2015-07-21
Просмотров: 973
Описание: Rubin Mesa MD, Serge Verstovsek MD, Richard Silver MD, and Emily Knight R.N., O.C.N. offer their perspectives and insights for optimal management of PV after hydroxyurea (HU) failure. HU is frequently used for first-line cytoreductive therapy in patients with PV, but some patients are poorly served, experiencing inadequate disease or symptom control, intolerable toxicity, or both, and may benefit from switching to a different therapy.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: